Pushing the envelope-nonmyeloablative and reduced intensity preparative regimens for allogeneic hematopoietic transplantation

被引:23
|
作者
Pingali, S. R. [1 ]
Champlin, R. E. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
关键词
STEM-CELL TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; 1ST COMPLETE REMISSION; CHRONIC LYMPHOCYTIC-LEUKEMIA; TERM-FOLLOW-UP; ACUTE MYELOGENOUS LEUKEMIA; TOTAL-BODY IRRADIATION;
D O I
10.1038/bmt.2015.61
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Allogeneic hematopoietic cell transplantation (HCT) was originally developed to allow delivery of myeloablative doses of chemotherapy and radiotherapy. With better understanding of disease pathophysiology, the graft vs malignancy (GVM) effect of allogeneic hematopoietic transplantation and toxicities associated with myeloablative conditioning (MAC) regimens, the focus shifted to developing less toxic conditioning regimens to reduce treatment-related morbidity without compromising survival. Although HCT with MAC is preferred to reduced intensity conditioning (RIC) for most patients <= 60 years with AML/myelodysplastic syndrome and ALL, RIC and nonmyeloablative (NMA) regimens allow HCT for many otherwise ineligible patients. Reduced intensity preparative regimens have produced high rates of PFS for diagnoses, which are highly sensitive to GVM. Relapse of the malignancy is the major cause of treatment failure with RIC/NMA HCT. Incorporation of novel agents like bortezomib or lenalidomide, addition of cellular immunotherapy and use of targeted radiation therapies could further improve outcome. In this review, we discuss commonly used RIC/NMA regimens and promising novel regimens.
引用
收藏
页码:1157 / 1167
页数:11
相关论文
共 50 条
  • [31] Prior autologous hematopoietic cell transplantation confers an adverse prognosis for recipients of allogeneic transplantation following nonmyeloablative preparative conditioning.
    Schiller, GJ
    Emmanouilides, C
    Paquette, R
    Rosen, P
    Gansert, J
    Territo, MC
    BLOOD, 2004, 104 (11) : 346B - 346B
  • [32] Oral mucositis in patients receiving reduced-intensity regimens for allogeneic hematopoietic cell transplantation: comparison with conventional regimen
    Takahashi, Kanayo
    Soga, Yoshihiko
    Murayama, Yumeno
    Udagawa, Mika
    Nishimoto, Hitomi
    Sugiura, Yuko
    Maeda, Yoshinobu
    Tanimoto, Mitsune
    Takashiba, Shogo
    SUPPORTIVE CARE IN CANCER, 2010, 18 (01) : 115 - 119
  • [33] Reduced-Intensity Compared to Nonmyeloablative Conditioning in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
    Nath, Karthik
    Peterson, Kristen
    Brown, Samantha
    Devlin, Sean
    Rodriguez, Natasia
    Barker, Juliet
    Giralt, Sergio
    Gyurkocza, Boglarka
    Jakubowski, Ann
    Papadopoulos, Esperanza
    Ponce, Doris
    Scordo, Michael
    Shah, Gunjan
    Perales, Miguel-Angel
    Sauter, Craig
    Lin, Andrew
    Dahi, Parastoo B.
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (01): : 81 - 92
  • [34] Oral mucositis in patients receiving reduced-intensity regimens for allogeneic hematopoietic cell transplantation: comparison with conventional regimen
    Kanayo Takahashi
    Yoshihiko Soga
    Yumeno Murayama
    Mika Udagawa
    Hitomi Nishimoto
    Yuko Sugiura
    Yoshinobu Maeda
    Mitsune Tanimoto
    Shogo Takashiba
    Supportive Care in Cancer, 2010, 18 : 115 - 119
  • [35] Feasibility of allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens for refractory myeloid malignancies.
    Hamaki, T
    Kami, M
    Kim, SW
    Yamamoto, R
    Imataki, O
    Suyama, H
    Arima, F
    Nakai, K
    Saito, T
    Kanda, Y
    Makimoto, A
    Tanosaki, R
    Mineishi, S
    Takaue, Y
    BLOOD, 2002, 100 (11) : 851A - 851A
  • [36] FAVORABLE OUTCOMES OF REDUCED-INTENSITY CONDITIONING REGIMENS FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR CHILDREN WITH ACUTE LEUKEMIA
    Koh, K.
    Seo, J.
    Choi, E.
    Im, H.
    Seo, J.
    HAEMATOLOGICA, 2013, 98 : 663 - 663
  • [37] Comparison of reduced intensity and nonmyeloablative conditioning for adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation in first or second remission
    Roland B. Walter
    Brenda M. Sandmaier
    Megan Othus
    Corentin Orvain
    Eduardo Rodríguez-Arbolí
    Masumi U. Oshima
    Gary Schoch
    Chris Davis
    H. Joachim Deeg
    Rainer Storb
    Bone Marrow Transplantation, 2023, 58 : 377 - 385
  • [38] Comparison of reduced intensity and nonmyeloablative conditioning for adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation in first or second remission
    Walter, Roland B.
    Sandmaier, Brenda M.
    Othus, Megan
    Orvain, Corentin
    Rodriguez-Arboli, Eduardo
    Oshima, Masumi U.
    Schoch, Gary
    Davis, Chris
    Joachim Deeg, H.
    Storb, Rainer
    BONE MARROW TRANSPLANTATION, 2023, 58 (04) : 377 - 385
  • [39] Transfusions after nonmyeloablative or reduced-intensity conditioning regimens
    Baron F.
    Vanstraelen G.
    Beguin Y.
    Leukemia, 2006, 20 (12) : 2081 - 2086
  • [40] Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: Current perspectives
    Sandmaier, Brenda M.
    Mackinnon, Stephen
    Childs, Richard W.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (01) : 87 - 97